Vera Therapeutics’ First-in-Class Kidney Disease Drug Lands Speedy FDA ApprovalNews DeskJuly 8, 20260 A rare autoimmune disease affecting the kidneys has a new FDA approved treatment, a first-in-class Vera Therapeutics drug whose approach…
Vertex Pharma’s Growth Strategy Leads to Its Biggest-Ever M&A DealNews DeskJuly 7, 20260 Vertex Pharmaceuticals is ramping up its portfolio and pipeline diversification efforts with the biggest deal in its history: the $10…
A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of CancerNews DeskJuly 6, 20260 Novartis is growing in oncology, but its moves to develop targeted cancer therapies had steered clear of antibody drug conjugates,…
Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis DrugNews DeskJuly 5, 20260 One of the standard treatments for idiopathic pulmonary fibrosis is an old drug that offers limited efficacy and a range…
With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer DrugsNews DeskJuly 2, 20260 Roche is a relative latecomer in the chase to block a protein called KRAS G12C to treat lung cancer, but…
Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living MedicineNews DeskJuly 2, 20260 Many blood cancers can be treated with a potentially curative stem cell transplant, but this procedure introduces a serious complication…